Showing results (911-920 of 1,142) with videos related to

Sort By:
Pageof 115
Journal of Hepatology|July 2, 2011
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group reportHenry Lik-Yuen Chan, Alex Thompson, Michelle Martinot-Peignoux, et al.
Therapeutic Advances in Gastroenterology|August 25, 2017
Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter studyBenjamin Maasoumy, Birgit Bremer, Patrick Lehmann, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 12, 2015
Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT studyHarald H Kessler, Bryan R Cobb, Heiner Wedemeyer, et al.
Plos One|August 21, 2012
Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infectionJerzy Jaroszewicz, Thomas Reiberger, Dirk Meyer-Olson, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Scientific Reports|February 20, 2020
Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinomaMai Thanh Binh, Nghiem Xuan Hoan, Dao Phuong Giang, et al.
European Journal of Clinical Pharmacology|September 30, 2022
Students' guide to documentation in clinical trialsJohannes Heck, Ann-Kathrin Rath, Katrin Wons, et al.
Gut|November 9, 2013
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis CM Colombo, I Fernández, D Abdurakhmanov, et al.
JHEP Reports : Innovation in Hepatology|April 2, 2025
QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosisChristian Labenz, Simon J Gairing, Leonard Kaps, et al.
The Journal of Infectious Diseases|September 10, 2016
Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis BChristoph Höner Zu Siederdissen, Franziska Rinker, Benjamin Maasoumy, et al.
Pageof 115